These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 30984170

  • 1. IgA and FcαRI: Pathological Roles and Therapeutic Opportunities.
    Breedveld A, van Egmond M.
    Front Immunol; 2019; 10():553. PubMed ID: 30984170
    [Abstract] [Full Text] [Related]

  • 2. The era of the immunoglobulin A Fc receptor FcαRI; its function and potential as target in disease.
    Aleyd E, Heineke MH, van Egmond M.
    Immunol Rev; 2015 Nov; 268(1):123-38. PubMed ID: 26497517
    [Abstract] [Full Text] [Related]

  • 3. Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration.
    Heineke MH, van der Steen LPE, Korthouwer RM, Hage JJ, Langedijk JPM, Benschop JJ, Bakema JE, Slootstra JW, van Egmond M.
    Eur J Immunol; 2017 Oct; 47(10):1835-1845. PubMed ID: 28736835
    [Abstract] [Full Text] [Related]

  • 4. IgA and FcαRI: Versatile Players in Homeostasis, Infection, and Autoimmunity.
    van Gool MMJ, van Egmond M.
    Immunotargets Ther; 2020 Oct; 9():351-372. PubMed ID: 33447585
    [Abstract] [Full Text] [Related]

  • 5. Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.
    Ben Mkaddem S, Rossato E, Heming N, Monteiro RC.
    Autoimmun Rev; 2013 Apr; 12(6):666-9. PubMed ID: 23201915
    [Abstract] [Full Text] [Related]

  • 6. The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.
    Bakema JE, van Egmond M.
    Mucosal Immunol; 2011 Nov; 4(6):612-24. PubMed ID: 21937986
    [Abstract] [Full Text] [Related]

  • 7. IgA and the IgA Fc receptor.
    van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG.
    Trends Immunol; 2001 Apr; 22(4):205-11. PubMed ID: 11274926
    [Abstract] [Full Text] [Related]

  • 8. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.
    Herr AB, Ballister ER, Bjorkman PJ.
    Nature; 2003 Jun 05; 423(6940):614-20. PubMed ID: 12768205
    [Abstract] [Full Text] [Related]

  • 9. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
    Valerius T, Stockmeyer B, van Spriel AB, Graziano RF, van den Herik-Oudijk IE, Repp R, Deo YM, Lund J, Kalden JR, Gramatzki M, van de Winkel JG.
    Blood; 1997 Dec 01; 90(11):4485-92. PubMed ID: 9373259
    [Abstract] [Full Text] [Related]

  • 10. The Fc receptor for IgA (FcalphaRI, CD89).
    Otten MA, van Egmond M.
    Immunol Lett; 2004 Mar 29; 92(1-2):23-31. PubMed ID: 15081523
    [Abstract] [Full Text] [Related]

  • 11. Immunoglobulin A: magic bullet or Trojan horse?
    Heineke MH, van Egmond M.
    Eur J Clin Invest; 2017 Feb 29; 47(2):184-192. PubMed ID: 28024097
    [Abstract] [Full Text] [Related]

  • 12. Immunoglobulin A-mediated protection against Bordetella pertussis infection.
    Hellwig SM, van Spriel AB, Schellekens JF, Mooi FR, van de Winkel JG.
    Infect Immun; 2001 Aug 29; 69(8):4846-50. PubMed ID: 11447159
    [Abstract] [Full Text] [Related]

  • 13. Anti-FcαRI Monoclonal Antibodies Resolve IgA Autoantibody-Mediated Disease.
    Bos A, Aleyd E, van der Steen LPE, Winter PJ, Heemskerk N, Pouw SM, Boon L, Musters RJP, Bakema JE, Sitaru C, Cogné M, van Egmond M.
    Front Immunol; 2022 Aug 29; 13():732977. PubMed ID: 35371001
    [Abstract] [Full Text] [Related]

  • 14. FcαRI binding at the IgA1 CH2-CH3 interface induces long-range conformational changes that are transmitted to the hinge region.
    Posgai MT, Tonddast-Navaei S, Jayasinghe M, Ibrahim GM, Stan G, Herr AB.
    Proc Natl Acad Sci U S A; 2018 Sep 18; 115(38):E8882-E8891. PubMed ID: 30181292
    [Abstract] [Full Text] [Related]

  • 15. Role of IgA and IgA fc receptors in inflammation.
    Monteiro RC.
    J Clin Immunol; 2010 Jan 18; 30(1):1-9. PubMed ID: 19834792
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
    Borrok MJ, Luheshi NM, Beyaz N, Davies GC, Legg JW, Wu H, Dall'Acqua WF, Tsui P.
    MAbs; 2015 Jan 18; 7(4):743-51. PubMed ID: 25970007
    [Abstract] [Full Text] [Related]

  • 17. Serum IgA Fc effector functions in infectious disease and cancer.
    Davis SK, Selva KJ, Kent SJ, Chung AW.
    Immunol Cell Biol; 2020 Apr 18; 98(4):276-286. PubMed ID: 31785006
    [Abstract] [Full Text] [Related]

  • 18. Episodes of natural selection shaped the interactions of IgA-Fc with FcalphaRI and bacterial decoy proteins.
    Abi-Rached L, Dorighi K, Norman PJ, Yawata M, Parham P.
    J Immunol; 2007 Jun 15; 178(12):7943-54. PubMed ID: 17548632
    [Abstract] [Full Text] [Related]

  • 19. Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells.
    Pasquier B, Lepelletier Y, Baude C, Hermine O, Monteiro RC.
    J Leukoc Biol; 2004 Dec 15; 76(6):1134-41. PubMed ID: 15371488
    [Abstract] [Full Text] [Related]

  • 20. FcalphaRI (CD89) alleles determine the proinflammatory potential of serum IgA.
    Wu J, Ji C, Xie F, Langefeld CD, Qian K, Gibson AW, Edberg JC, Kimberly RP.
    J Immunol; 2007 Mar 15; 178(6):3973-82. PubMed ID: 17339498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.